Foghorn Therapeutics and Eli Lilly discontinue their SMARCA2 degrader program, Novartis licenses Abogen's autoimmune mRNA therapy while AstraZeneca, Daiichi Sankyo, and Summit Therapeutics team up on a breast cancer combination trial, and Corxel's Bo Liang makes the case for oral GLP-1 therapies.

On this week's episode, Graig Suvannavejh, Sam Fazeli, Eric Schmidt, and Brian Skorney open with a look at the public markets, noting the XBI is up 27% year-to-date but down about 9% since its August high. The co-hosts then touched on Oura's pulled IPO, seeing little read-through for the broader biotech space. In deals, Sanofi and Regeneron extended their antibody collaboration for $1 billion upfront and up to $7 billion in milestones, while AstraZeneca and Daiichi Sankyo struck deals with

W 18. odcinku podcastu „AI pod CTRL-ą” Paulina Cecko i Michał Sierlecki zgłębiają dynamiczny rozwój oraz dramatyczne wyzwania związane z wykorzystaniem sztucznej inteligencji w medycynie. Z jednej strony przyglądamy się spektakularnym przełomom diagnostycznym – takim jak opracowany przez Mayo Clinic model REDMOD, który potrafi wykryć raka trzustki na rutynowych skanach tomograficznych aż 16 miesięcy przed diagnozą kliniczną, czy koncepcji „medycznej superinteligencji” w postaci Microsoft AI

Thorne et al., Proceedings of the National Academy of Sciences - GLP-1 receptor agonists such as semaglutide produce large weight loss, but part of what is lost is lean mass, energy expenditure falls, and weight tends to return when treatment stops. This study tests a complementary idea in mice: switching on heat-producing fat by silencing ZFP423, a repressor of brown and beige fat identity, with an adipose-targeted antisense oligonucleotide. The RNA drug

Bu bölümde, Suudi Gıda ve İlaç Kurumu'nun (SFDA) 7 Eylül 2026'da yanıltıcı bir tıbbi cihaz reklamı nedeniyle bir şirkete karşı başlattığı yasal işlemi inceliyoruz. Hafif osteoartrit cihazı reklamındaki abartılı iddiaların yol açtığı bu olay, Suudi Arabistan'da tıbbi cihaz tanıtım kurallarının ne kadar katı olduğunu gösteriyor. 5 milyon Suudi Riyali'ne varan olası para cezalarını, uyumsuzluk risklerini ve ruhsatlandırma ile pazarlama ekiplerinin bu tür cezalardan kaçınmak için alması gereken pratik

Saudiarabiens livsmedels- och läkemedelsmyndighet (SFDA) har vidtagit verkställighetsåtgärder mot ett företag för vilseledande reklam för en medicinteknisk produkt. Händelsen, som rapporterades den 7 september 2026, involverade överdrivna påståenden om en produkt för artros och kan leda till böter på upp till 5 miljoner saudiska riyal. Det här avsnittet analyserar SFDA:s åtgärd, förklarar de regulatoriska kraven för reklam för medicintekniska produkter i Saudiarabien och ger praktiska steg för

A Autoridade Saudita de Alimentos e Medicamentos (SFDA) está a intensificar a fiscalização da publicidade de dispositivos médicos, como evidenciado por uma ação legal recente em 7 de setembro de 2026, contra uma empresa por alegações de marketing enganosas. Com multas potenciais de até 5 milhões de riais sauditas, os fabricantes devem garantir que todos os materiais promocionais sejam precisos, substanciados e pré-aprovados pela SFDA. Este episódio explora os detalhes da violação, as implicações

Cet épisode analyse l'action coercitive de l'Autorité saoudienne des produits alimentaires et des médicaments (SFDA) du 7 septembre 2026 contre une publicité trompeuse pour un dispositif médical. Nous discutons des violations spécifiques, des sanctions potentielles pouvant atteindre 5 millions de riyals saoudiens, et des mesures pratiques que les entreprises de technologie médicale doivent prendre pour garantir la conformité de leurs supports promotionnels sur le marché saoudien.Key Questions: -

इस एपिसोड में, हम 7 सितंबर, 2026 को सऊदी खाद्य एवं औषधि प्राधिकरण (SFDA) द्वारा एक चिकित्सा उपकरण कंपनी के खिलाफ की गई प्रवर्तन कार्रवाई पर चर्चा करते हैं। कंपनी पर हल्के ऑस्टियोआर्थराइटिस उपकरण के लिए अपने विज्ञापन में भ्रामक और अतिरंजित दावे करने का आरोप लगाया गया था। हम इस उल्लंघन के विवरण, 5 मिलियन सऊदी रियाल तक के संभावित दंड, और सऊदी अरब में अपने उत्पादों का विपणन करने वाली सभी चिकित्सा प्रौद्योगिकी कंपनियों के लिए इसके निहितार्थों का विश्लेषण करते हैं। यह एपिसोड आपके विज्ञापन और प्रचार

Trong tập này, chúng tôi phân tích hành động thực thi gần đây của Cơ quan Quản lý Thực phẩm và Dược phẩm Ả Rập Xê Út (SFDA) đối với một công ty vì quảng cáo thiết bị y tế gây hiểu lầm. Chúng tôi thảo luận về các vi phạm cụ thể, các hình phạt tiềm tàng lên tới 5 triệu SR và ý nghĩa rộng lớn hơn đối với các nhà sản xuất muốn tiếp thị sản phẩm của họ tại Vương quốc Ả Rập Xê Út. Hãy lắng nghe để tìm hiểu các bước thực tế nhằm đảm bảo các tài liệu quảng cáo của bạn tuân thủ các quy định nghiêm ngặt của

В этом выпуске мы обсуждаем недавние правоприменительные меры Управления по санитарному надзору за качеством пищевых продуктов и медикаментов Саудовской Аравии (SFDA) в отношении компании, разместившей недобросовестную рекламу медицинского изделия. Седьмого сентября 2026 года SFDA инициировало судебное разбирательство из-за неточных и преувеличенных заявлений в рекламе устройства для лечения остеоартрита. Мы анализируем последствия этого события, включая возможные штрафы до 5 миллионов саудовских

Otoritas Makanan dan Obat Arab Saudi (SFDA) baru-baru ini mengambil tindakan penegakan hukum terhadap iklan perangkat medis yang menyesatkan, menyoroti pengawasan ketat terhadap materi promosi. Episode ini membahas pelanggaran spesifik terkait klaim yang tidak akurat dan berlebihan untuk perangkat osteoartritis, potensi denda hingga SR5 juta, dan implikasinya bagi produsen. Kami memberikan langkah-langkah praktis yang dapat diambil oleh tim regulasi dan pemasaran untuk memastikan kepatuhan dan

Is "AI is dangerous" a warning, or the world's best marketing line?This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at agelessrx.com/beyond-tomorrow.On this episode of Beyond Tomorrow, I sit down with Thore Graepel, co-creator of AlphaGo and former researcher at Google DeepMind. I asked him straight up

TWiP explains a single-cell analysis of immune cells in the blood of dogs with canine leishmaniosis, providing a detailed picture of how the immune response changes as the disease progresses. Hosts: Vincent Racaniello, Daniel Griffin, and Christina Naula Subscribe (free): Apple Podcasts, RSS, email Links for this episode Join the MicrobeTV Discord server Single immune cell atlas of canine leishmaniosis (iScience) Clinical staging in CanL (LeishVet) TWiP study – information and survey Become

While falls can happen to anyone, older adults are more likely to experience serious injuries as a result. That's why falls prevention is an important public health issue for all of us, not just for older adults but also for their families, caregivers, and communities. In this episode, Dr. Carol Petrie, a board certified expert in geriatric physical therapy and falls prevention talks about the best ways to reduce our risk of falling, when we should begin thinking about it, advice for caregive...

What if the biggest challenge in biotech isn't innovation, but adoption?I'm joined by Holley Miller, CEO of Grey Matter Marketing, to explore why better science doesn't automatically win.We talk about why people buy outcomes rather than products, why emotion can open the door before data earns belief, the importance of solving an urgent problem, and why being different can sometimes matter more than simply being better.Holley also shares her own entrepreneurial and leadership journey,

CEO Markus Warmuth walks us through the data and provides a broader update on the pipeline progress at Monte Rosa and for the field of degraders and molecular glues more broadly.

Dr. Don and Professor Ben talk about the risks from consuming or preparing Vichy squirrel. Dr. Don - risky ☣️ Professor Ben - risky ☣️ Vichy - Wikipedia Mortar and pestle - Wikipedia Monty Python - The French Taunter - HD WITH ENGLISH SUBTITLES - YouTube Native and introduced squirrels in Italy host different Cryptosporidium spp. - ScienceDirect A Peek into the Bacterial Microbiome of the Eurasian Red Squirrel (Sciurus vulgaris) What Diseases Can Squirrels Carry? - Varmint Gone All About

In this episode, Prof Gianluca Gaidano, recipient of the EHA2026 Diversity, Equity and Inclusion Award, explores how promoting equity, inclusion, and access to care has shaped his work within EHA and beyond. He reflects on educational initiatives in underrepresented regions, including Africa, the Middle East, Asia, and South America, and explains how international collaborations can help expand access to medical knowledge, advanced diagnostics, and innovative therapies.  The discussion explores the

Send us Fan Mail The 2026 Guideline for Adult Stroke Rehabilitation and Recovery from the American Heart Association and American Stroke Association is a major update to how we understand stroke rehabilitation, recovery, and long term care. This is a conversation about the evidence, the gaps, and what happens when stroke rehabilitation recommendations meet the people actually living them. In this episode of Brain Friends, Angie sits down with Dr. Lorie G. Richards, PhD, OTR/L, FAHA, occupatio...